Revenue: The sum of all revenue fields included for a company's operating activities.
Maravai LifeSciences Holdings, Inc. (MRVI) had Revenue of $74.14M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$74.14M |
$-105.96M |
|
$35.11M |
|
$39.03M |
|
$81.29M |
|
$-7.15M |
|
$663.34M |
|
$656.19M |
|
$656.19M |
|
$-109.98M |
|
$-109.98M |
|
$-109.98M |
|
$-109.98M |
|
$-7.15M |
|
$6.57M |
|
131.92M |
|
131.92M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$699.91M |
|
$162.90M |
|
$787.54M |
|
$1.49B |
|
$87.47M |
|
$550.60M |
|
$610.10M |
|
$697.57M |
|
$789.88M |
|
$242.87M |
|
$789.88M |
|
251.32M |
|
| Cash Flow Statement Financials | |
$126.22M |
|
$-122.31M |
|
$-61.09M |
|
$632.14M |
|
$574.96M |
|
$-57.18M |
|
$34.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.00 |
|
-- |
|
-- |
|
0.41 |
|
0.70 |
|
52.65% |
|
-9.64% |
|
-9.64% |
|
-- |
|
885.05% |
|
-142.92% |
|
$60.67M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.68 |
|
1.33 |
|
67.64 |
|
-13.92% |
|
-45.28% |
|
-7.39% |
|
-8.20% |
|
$3.14 |
|
$0.46 |
|
$0.96 |
|